Migraine news this week: June 18

Catch up on the headlines.

Lilly and American Migraine Foundation Announce $1 Million Grant for Launch of First Patient Registry to Advance Research and Development in Migraine

MRF congratulates the American Migraine Foundation on the major funding to launch a migraine patient registry, which will help advance and improve migraine research. MRF also thanks Eli Lilly and Company for their dedication to migraine research!

Dizzy and Disoriented, With No Cure in Sight

A personal essay in the New York Times Well blog paints a vivid picture of vestibular migraine and shows us exactly why we need more migraine research.

Vitamin Deficiencies May Prompt Chronic Migraines

MRF Medical Advisory Board member Dr. Andrew Hershey found that young migraine sufferers are much more likely to be deficient in vitamin D, riboflavin, and coenzyme Q10. These results suggest doctors should prioritize screening all migraine sufferers for vitamin deficiencies and considering supplements as an important treatment.

Men with Migraine Are Less Likely Than Women to Be Diagnosed and Treated

MRF grantee Dr. Ann Scher and MRF Medical Advisory Board member Dr. Richard Lipton joined together to search for differences between male and female migraine sufferers by surveying them online. They determined that men are less likely then women to see a doctor for their headaches, and to receive a diagnosis of migraine when they do. The authors suggest that the perception of migraine as a women’s disease is causing this discrepancy, and that we need to work to de-stigmatize migraine so all sufferers can be diagnosed and treated properly.

New MRF Research Alert: Two migraine genetics studies have been completed

MRF/AMD Grantee Dr. Lyn Griffiths used a targeted method to identify genetic mutations associated with familial hemiplegic migraine that allowed her to screen many genes at the same time. She was able to identify 24 different mutations in FHM sufferers.

This method provided a faster, more cost-effective and comprehensive analysis than is typically used and will make it easier to diagnose FHM and enable more effective treatment choices. Read the full report.

MRF/AMD Grantees Dr. Robert Shapiro and Dr. Gary Mawe investigated whether changes in the brain that occur during migraine are also expressed in the nervous system of the GI tract in mice. They found that genetic mutations that can increase migraine susceptibility were not a major cause of gastrointestinal motility abnormalities. Read the full report.